These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30256029)

  • 21. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
    Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
    Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients.
    Guo Y; Liu S; Hu S; Li F; Jin L
    Front Endocrinol (Lausanne); 2021; 12():673284. PubMed ID: 34122349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients.
    Xi W; Gong F; Lu G
    J Assist Reprod Genet; 2012 May; 29(5):397-402. PubMed ID: 22382641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study.
    Tshzmachyan R; Hambartsoumian E
    J Gynecol Obstet Hum Reprod; 2020 Feb; 49(2):101643. PubMed ID: 31563697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
    Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
    Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective use of corifollitropin for controlled ovarian stimulation for IVF in patients with low anti-Müllerian hormone.
    Nielsen AP; Korsholm AS; Lemmen JG; Sylvest R; Sopa N; Nyboe Andersen A
    Gynecol Endocrinol; 2016 Aug; 32(8):625-628. PubMed ID: 26891977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic ovarian drilling before IVF/ICSI in polycystic ovarian syndrome patients with high antimullarian hormone.
    Abdelhafez MS; Shams M; Abdel-Razik MM; Wageh A
    J Gynecol Obstet Hum Reprod; 2022 Mar; 51(3):102324. PubMed ID: 35063718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the measurement of anti-Müllerian hormone essential?
    Usta T; Oral E
    Curr Opin Obstet Gynecol; 2012 Jun; 24(3):151-7. PubMed ID: 22487725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome.
    Li F; Chen Y; Niu A; He Y; Yan Y
    Front Endocrinol (Lausanne); 2021; 12():619059. PubMed ID: 34421814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.
    Aghssa MM; Tarafdari AM; Tehraninejad ES; Ezzati M; Bagheri M; Panahi Z; Mahdavi S; Abbasi M
    Reprod Health; 2015 Sep; 12():85. PubMed ID: 26357853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.
    Cerra C; Newman WG; Tohlob D; Byers H; Horne G; Roberts SA; Mohiyiddeen L
    J Assist Reprod Genet; 2016 Aug; 33(8):1085-91. PubMed ID: 27142041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational study.
    Li R; Gong F; Zhu Y; Fang W; Yang J; Liu J; Hu L; Yang D; Liang X; Qiao J
    Reprod Biomed Online; 2016 Oct; 33(4):506-512. PubMed ID: 27502068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
    Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.